Kevin B. Laupland

Molecular Medicine · 2004–2008

A researcher in the Science corpus: 4 papers; trusts 4 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom Kevin B. Laupland trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. R. Bonnet
  2. P. Bradford
  3. Henry F. Chambers
  4. D. Livermore

Who trusts Kevin B. Laupland overall

  1. C. Ewers
  2. P. Nordmann

Papers from Kevin B. Laupland's perspective

Ordered by how strongly the researchers Kevin B. Laupland trusts endorse each paper. Same corpus, a different order for every researcher.

  1. APACHE II: A severity of disease classification system
  2. Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes (Antimicrobial Agents and Chemotherapy)
  3. Acute renal failure in critically ill patients: a multinational, multicenter study. (Journal of the American Medical Association (JAMA))
  4. Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat (Clinical Microbiology Reviews)
  5. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients* (Critical Care Medicine)
  6. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score (Intensive Care Medicine)
  7. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
  8. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study.
  9. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. (The Lancet)
  10. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis (Critical Care)

Their papers